NCT01513967 - A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Healthy VolunteersModerate to Severe Alzheimer Patients

Interventions

DRUG

RPh201, botanical drug product

SC administration at varying doses

DRUG

Placebo

SC administration at varying doses

Trial Locations (2)

Toronto Memory Program, Toronto

Kendle Early Stage - Toronto, Toronto